| Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer | A Phase II Trial of Perillyl Alcohol in Patients With Resectable Pancreatic Cancer | NCT00003769 |
| Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer | A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily in Patients With Metastatic Breast Cancer | NCT00003219 |
| Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy | Multiple-Dose Phase I and Pharmacokinetic Trial of Perillyl Alcohol | NCT00022425 |
| Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses | Phase 2a Randomized, Placebo-Controlled, Double-Blind Trial of Topical Perillyl Alcohol in Sun Damaged Skin | NCT00608634 |
| Pilot study of a clinical trial comparing patients with a type of brain tumor who will undergo radiotherapy and chemotherapy treatment with those who will undergo this treatment combined with the use of the medication Perillyl Alcohol by inhalation | Pilot study of a randomized clinical trial comparing patients with Glioblastoma undergoing standard treatment (radiotherapy and chemotherapy) versus standard treatment combined with the use of Intranasal Perillyl Alcohol | RBR-4ngc9n5 |
| Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily In Patients With Metastatic Androgen Independent Prostate Cancer | NCT00003238 |
| Perillyl Alcohol in Treating Patients With Refractory Cancer | A PHASE I STUDY OF PERILLYL ALCOHOL IN PATIENTS WITH REFRACTORY MALIGNANCIES (NSC #641066) | NCT00002862 |
